CR Group L.P. — SEC Form 4 filings
SEC reporting owner CIK 1702352. 4 Form 4 filings on record with FilingPulse; latest filed 2024-05-13.
Transaction summary — filings shown
Covers all 4 filings on record, filed 2024-02-16 to 2024-05-13. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 19.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| T2 Biosystems, Inc. (TTOO) | 10% owner | 4 | — | — | 19 |
Form 4 filings — CR Group L.P.
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2024-05-13 | 4 | T2 Biosystems, Inc. (TTOO) jointly with CRG Partners III (Cayman) Lev AIV I L.P., CRG Partners III - Parallel Fund B (Cayman) L.P., CRG Partners III L.P., CRG Partners III - Parallel Fund (A) L.P., CRG Partners III (Cayman) Unlev AIV I L.P. | Conversion (C): 1,716,048 · Conversion (C): 108,752 · Conversion (C): 17,160.48 (derivative) @ $0 · Conversion (C): 10,875.25 (derivative) @ $0 | EDGAR |
| 2024-05-07 | 4 | T2 Biosystems, Inc. (TTOO) jointly with CRG Partners III (Cayman) Lev AIV I L.P., CRG Partners III - Parallel Fund B (Cayman) L.P., CRG Partners III L.P., CRG Partners III - Parallel Fund (A) L.P., CRG Partners III (Cayman) Unlev AIV I L.P. | Grant/award (A): 648,139 · Grant/award (A): 403,608 · Grant/award (A): 129,629 · Grant/award (A): 1,565,445 · Grant/award (A): 2,001,514 | EDGAR |
| 2024-04-16 | 4 | T2 Biosystems, Inc. (TTOO) jointly with CRG Partners III (Cayman) Lev AIV I L.P., CRG Partners III - Parallel Fund B (Cayman) L.P., CRG Partners III L.P., CRG Partners III - Parallel Fund (A) L.P., CRG Partners III (Cayman) Unlev AIV I L.P. | Grant/award (A): 682,036 · Grant/award (A): 424,716 · Grant/award (A): 136,409 · Grant/award (A): 1,647,315 · Grant/award (A): 390,142 · Grant/award (A): 17,160.48 (derivative) @ $0 | EDGAR |
| 2024-02-16 | 4 | T2 Biosystems, Inc. (TTOO) jointly with CRG Partners III (Cayman) Lev AIV I L.P., CRG Partners III - Parallel Fund B (Cayman) L.P., CRG Partners III L.P., CRG Partners III - Parallel Fund (A) L.P., CRG Partners III (Cayman) Unlev AIV I L.P. | Conversion (C): 335,947 · Conversion (C): 488,273 · Conversion (C): 33,594.71 (derivative) @ $0 · Conversion (C): 48,827.30 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1702352 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →